Cargando…

Co-loaded lapatinib/PAB by ferritin nanoparticles eliminated ECM-detached cluster cells via modulating EGFR in triple-negative breast cancer

Cancer stem cell (CSC) cluster of triple-negative breast cancer (TNBC) is suggested to be responsible for therapy resistance, metastatic process and cancer recurrence, yet the sensitivity of CSC clusters of TNBC to ferroptosis remains elusive in a great measure. Current research revealed that epider...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xinghan, Sheng, Huan, Zhao, Liping, Jiang, Mingxia, Lou, Han, Miao, Yue, Cheng, Ni, Zhang, Weifen, Ding, Dejun, Li, Wentong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209505/ https://www.ncbi.nlm.nih.gov/pubmed/35725558 http://dx.doi.org/10.1038/s41419-022-05007-0

Ejemplares similares

Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer
por: Li, Zihaoran, et al.
Publicado: (2021)

Targeted exosome‐encapsulated erastin induced ferroptosis in triple negative breast cancer cells
por: Yu, Mengyu, et al.
Publicado: (2019)

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
por: Simiczyjew, Aleksandra, et al.
Publicado: (2018)

Reprogramming of iron metabolism confers ferroptosis resistance in ECM-detached cells
por: He, Jianping, et al.
Publicado: (2023)

Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy
por: Jiang, Mingxia, et al.
Publicado: (2021)

Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
por: Zhang, Weifen, et al.
Publicado: (2018)

Distortions of parliamentary amendments to the equitable allocation of federal resources to the PAB
por: Vieira, Fabiola Sulpino, et al.
Publicado: (2022)

Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors
por: Widatalla, Sarrah E, et al.
Publicado: (2019)

EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts
por: YALÇIN KEHRİBAR, Demet, et al.
Publicado: (2022)

Novel protein fold discovered in the PabI family of restriction enzymes
por: Miyazono, Ken-ichi, et al.
Publicado: (2007)

MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells
por: Gai, Chengcheng, et al.
Publicado: (2020)

Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment
por: Dai, Yalan, et al.
Publicado: (2023)

Hybrid polycaprolactone/hydrogel scaffold fabrication and in-process plasma treatment using PABS
por: Liu, Fengyuan, et al.
Publicado: (2018)

Cyclodextrin-Modified CeO(2) Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis
por: Wu, Lingyun, et al.
Publicado: (2020)

Impact of poly(A)-tail G-content on Arabidopsis PAB binding and their role in enhancing translational efficiency
por: Zhao, Taolan, et al.
Publicado: (2019)

ECM signals ECM degradation
por: Powell, Kendall
Publicado: (2006)

Expression, purification and structural analysis of the Pyrococcus abyssi RNA binding protein PAB1135
por: Luz, Juliana S, et al.
Publicado: (2010)

Pab1 acetylation at K131 decreases stress granule formation in Saccharomyces cerevisiae
por: Sivananthan, Sangavi, et al.
Publicado: (2022)

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer
por: Stringer-Reasor, Erica M., et al.
Publicado: (2021)

Structure of the Archaeal Pab87 Peptidase Reveals a Novel Self-Compartmentalizing Protease Family
por: Delfosse, Vanessa, et al.
Publicado: (2009)

Introns Regulate Gene Expression in Cryptococcus neoformans in a Pab2p Dependent Pathway
por: Goebels, Carolin, et al.
Publicado: (2013)

Differential amplification of satellite PaB6 in chromosomally hypervariable Prospero autumnale complex (Hyacinthaceae)
por: Emadzade, Khatere, et al.
Publicado: (2014)

Transmission of the PabI family of restriction DNA glycosylase genes: mobility and long-term inheritance
por: Kojima, Kenji K., et al.
Publicado: (2015)

Determining Pro-Oxidant Antioxidant Balance (PAB) and Total Antioxidant Capacity (TAC) in Patients with Schizophrenia
por: Zahedi Avval, Farnaz, et al.
Publicado: (2018)

La, PTB, and PAB proteins bind to the 3(′) untranslated region of Norwalk virus genomic RNA
por: Gutiérrez-Escolano, Ana Lorena, et al.
Publicado: (2003)

Distortion of double-stranded DNA structure by the binding of the restriction DNA glycosylase R.PabI
por: Miyazono, Ken-ichi, et al.
Publicado: (2020)

Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease
por: Chen, Qingquan, et al.
Publicado: (2021)

The Binding Specificity of PAB1 with Poly(A) mRNA, Regulated by Its Structural Folding
por: Padariya, Monikaben, et al.
Publicado: (2022)

Oncogenic signaling inhibits c-FLIP(L) expression and its non-apoptotic function during ECM-detachment
por: Tsegaye, Matyas Abel, et al.
Publicado: (2021)

Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2
por: Kim, Hwang-Phill, et al.
Publicado: (2009)

Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
por: Konecny, G E, et al.
Publicado: (2008)

Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models
por: Lubet, Ronald A., et al.
Publicado: (2018)

Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models
por: Lubet, Ronald A., et al.
Publicado: (2019)

Tetrameric structure of the restriction DNA glycosylase R.PabI in complex with nonspecific double-stranded DNA
por: Wang, Delong, et al.
Publicado: (2016)

Postural alterations in breast cancer survivors: proposal of the PABS evaluation protocol based on a systematic review
por: DORO, Elisa, et al.
Publicado: (2023)

Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
por: Chen, Yun-Ju, et al.
Publicado: (2013)

Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain
por: Wan, Xu, et al.
Publicado: (2016)

Astragalus Polysaccharides/Chitosan Microspheres for Nasal Delivery: Preparation, Optimization, Characterization, and Pharmacodynamics
por: Wang, Saisai, et al.
Publicado: (2020)

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
por: Diaz, Roque, et al.
Publicado: (2010)

Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes
por: Micek, Hannah M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2e448b0j663gjsdsj0tjd410b1